RCT Abstract - Varenicline and nicotine replacement therapy for smokers admitted to hospitals: a randomized, placebo-controlled trial - Milan 2023

ALERT 3: Keeping lungs healthy for life

Chair(s): Florence Schleich, Charlotte Suppli Ulrik, Kjeld Hansen, Jonathan Grigg, Asli Gorek Dilektasli

Session type: Clinical trials session

RCT Abstract - Varenicline and nicotine replacement therapy for smokers admitted to hospitals: a randomized, placebo-controlled trial

Michael J. Abramson

EVENTS HOME

Previous presentation

Next presentation

Session content

Embedding smoking cessation support into targeted lung health checks in the UK increases long-term smoking abstinence, 12-month follow-up data from two clinical randomised controlled trials.

Parris Williams

Replay

Abstract

Slides

RCT Abstract - Varenicline and nicotine replacement therapy for smokers admitted to hospitals: a randomized, placebo-controlled trial

Michael J. Abramson

Replay

Abstract

Slides

Wrap-up by discussant and discussion

Asli Gorek Dilektasli

Replay

Slides

Impact of exposure reduction recommendations on health outcomes in children with asthma during high desert dust season in Greece and Cyprus: Results of the MEDEA randomised trial

Panayiotis Kouis

Replay

Abstract

Slides

A cluster randomised controlled trial to reduce respiratory effects of cotton dust exposure among textile workers the MultiTex RCT study

Asaad Ahmed Nafees

Replay

Abstract

Slides

Wrap-up by discussant and discussion

Jonathan Grigg

Replay

Slides

Closing remarks

Replay

Session aims

The ALERT sessions (Abstracts Leading to Evolution in Respiratory Medicine Trials) showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, discussants, session chairs and the audience will actively discuss the showcased trials.

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}